Waves of resistance: Staphylococcus aureus in the antibiotic era

By Henry F. Chambers, F. DeLeo. Nature Reviews Microbiology, 2009

2,685 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Infectious Diseases, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/6852df7f1cd26d24eb349ae313b756175003d7b1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

1. M. Huemer
2. S. Brugger
3. Annelies S. Zinkernagel
4. Srikanth Mairpady Shambat
5. Victor J. Torres
6. Kunyan Zhang
7. Sahreena S. Lakhundi

In Infectious Diseases

1. Victor J. Torres
2. Tamara Reyes-Robles
3. M. Huemer
4. S. Brugger
5. Annelies S. Zinkernagel
6. Srikanth Mairpady Shambat
7. F. DeLeo
8. Kunyan Zhang

In Public Health, Environmental and Occupational Health

1. M. Huemer
2. S. Brugger
3. Annelies S. Zinkernagel
4. Srikanth Mairpady Shambat
5. Victor J. Torres
6. F. DeLeo
7. Kunyan Zhang
8. Sahreena S. Lakhundi

Citations in the corpus

• Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology (2018, background): “the mid-1990s, and LA-MRSA clones from the beginning of this century (15, 421, 422).”
• Geospatial Resolution of Human and Bacterial Diversity with City-Scale Metagenomics (2015, neutral): “…a grouping in reported ethnicity (self-reported as White, Black, Asian, Hispanic) from all areas of an imagesegmented U.S. Census Map (Figure S4) (Clinton et al., 2010), then compared these to samples wherein we observed enough human-mapping reads to call variants (see Supplemental Experimental…”
• Exploiting dominant‐negative toxins to combat Staphylococcus aureus pathogenesis (2016, neutral): “aureus) is a significant human pathogen that can cause a range of diseases from mild (such as skin and soft tissue infections) to severe and life-threatening infections including endocarditis, osteomyelitis, bacteremia, pneumonia, and sepsis [1].”
• Novel Staphylococcal Glycosyltransferases SdgA and SdgB Mediate Immunogenicity and Protection of Virulence-Associated Cell Wall Proteins (2013, neutral): “aureus (MRSA) is USA300, which has the capacity to produce a large number of virulence factors and cause mortality in infected individuals [1].”
• Rapid Neutrophil Destruction following Phagocytosis of Staphylococcus aureus (2010, background): “]. Although progress has been made, the mechanisms used by bacterial pathogens to evade killing by neutrophils are incompletely defined. S. aureus remains a significant health problem worldwide and is the leading cause of bacterial infections in the United States. The high prevalence of these infec”
• Staphylococcus aureus targets the Duffy antigen receptor for chemokines (DARC) to lyse erythrocytes (2015, background): “S. aureus infections range from minor skin and soft tissue infections, to more invasive and life threating infections like sepsis, endocarditis, osteomyelitis, and pneumonia (Chambers and Deleo, 2009).”
• Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States (2019, neutral): “aureus strain epidemiology have occurred (22).”